University of Queensland researchers have found targeting amyloid plaque in the brain is not essential for ultrasound to deliver cognitive improvement in neurodegenerative disorders.
Flagship recruits former BMS, Celgene R&D chief Rupert Vessey
After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an